About
Sensydia is developing a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.
Technologies
OutlookMicrosoft Office 365Google Cloud HostingGoogle Tag ManagerWixYouTubeVarnishMobile FriendlyRemote
Keywords
medical equipment manufacturingnon-invasive hemodynamicsclinical researchheart failurepoint-of-care systemwireless sensorspatient outcomeshealthcare equipment & suppliesheart failure managementcardiac monitoringclinical decision supportcost reductionb2bservicesreal-time dataautomated detectionai-driven diagnosticsearly detectioncloud-based reportingautomated cardiac abnormality detectionhemodynamic parametershealthtechejection fractioncardiologydiagnosis and managementnon-invasive cardiac assessmentmachine learning algorithmshealthcare technologycardiac performance systemmedical devices
Company Information
- Employees14
- Founded2015
- Annual Revenue$4000000
- Total Funding$11000000
Location
10880 Wilshire Blvd, Los Angeles, California, United States, 90024
